Results 181 to 190 of about 1,106,781 (260)

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito   +8 more
wiley   +1 more source

Tourist satisfaction as a mediator between event quality and economic outcomes: evidence from a Silk Road heritage destination. [PDF]

open access: yesFront Sports Act Living
Omonova N   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy